Core Viewpoint - Chongqing Huason Pharmaceutical Co., Ltd. has announced its profit distribution plan for the first half of 2025, which includes a cash dividend of RMB 0.35 per 10 shares, totaling approximately RMB 14.62 million, to be distributed to all shareholders [1][2]. Profit Distribution Plan - The profit distribution plan was approved at the fourth board meeting on August 21, 2025, with the total share base being 417,596,314 shares [1][2]. - The cash dividend will be distributed as follows: RMB 0.35 per 10 shares (before tax) for all shareholders, while specific tax rates apply for different categories of investors [2]. Dividend Payment Dates - The record date for the dividend distribution is set for September 8, 2025, and the ex-dividend date is September 9, 2025 [2]. Distribution Recipients - The recipients of the dividend will be all shareholders registered with the China Securities Depository and Clearing Corporation Limited, Shenzhen Branch, as of the record date [3]. Distribution Method - Cash dividends for A-share shareholders will be directly credited to their accounts through their securities companies on the ex-dividend date [3]. - The company will bear all legal responsibilities if there are any discrepancies in the dividend distribution due to changes in shareholders' accounts during the application period [3]. Reference Documents - The announcement includes references to the resolutions from the 2024 annual general meeting and the second meeting of the fourth board of directors, along with confirmation documents from the China Securities Depository and Clearing Corporation [4].
华森制药: 2025年半年度权益分派实施公告